ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 22 Issue : 4
Current Issue Archive Popular Article Ahead of Print

   
Quick Search





 
Effect of octreotide in the prevention of doxorubicin cardiotoxicity [Anatol J Cardiol]
Anatol J Cardiol. 2005; 5(1): 18-23

Effect of octreotide in the prevention of doxorubicin cardiotoxicity

Cem Barçın1, Hürkan Kurşaklıoğlu2, Mükerrem Safalı3, Atilla İyisoy4, Sedat Köse1, Nadir Barındık5, Ersoy Işık6
1Department of Cardiology, Gülhane Military Medical Academy, Ankara, Turkey
2Department of Cardiology, School of Medicine, Gülhane Military Medical Academy, Ankara, Turkey
3Department of Pathology, Gulhane Military Medical Academy, Ankara, Turkey
4Department of Aerospace Medicine, Gulhane Military Academy, Eskişehir
5Department of Cardiology, Gulhane Military Medical Academy, Ankara, Turkey
6Department of Cardiology School of Medicine, Gülhane Military Medical Academy, Etlik, Ankara

Original Article Effect of octreotide in the prevention of doxorubicin cardiotoxicity Cem Barçın 1, Hürkan Kurşaklıoğlu 2, Mükerrem Safalı 3, Atilla İyisoy 4, Sedat Köse 1, Nadir Barındık 5, Ersoy Işık 6 1 Department of Cardiology, Gülhane Military Medical Academy, Ankara, Turkey 2 Department of Cardiology, School of Medicine, Gülhane Military Medical Academy, Ankara, Turkey 3 Department of Pathology, Gulhane Military Medical Academy, Ankara, Turkey 4 Department of Aerospace Medicine, Gulhane Military Academy, Eskişehir 5 Department of Cardiology, Gulhane Military Medical Academy, Ankara, Turkey 6 Department of Cardiology School of Medicine, Gülhane Military Medical Academy, Etlik, Ankara Anatol J Cardiol 2005; 5: 18-23 This article was viewed 145 times, downloaded 128 times Key Words: Doxorubicin, cardiotoxicity, prevention, octreotide Full Text (PDF) Related Articles Send a comment Share Abstract Objective: A precise method for prevention from doxorubicin cardiotoxicity is not known. We examined whether octreotide has a protective effect against doxorubicin cardiotoxicity. Methods: New Zealand rabbits (n=44) were divided into 4 groups according to drugs given: Group A (n=12) doxorubicin and octreotide, Group B (n=12) only doxorubicin, Group C (n=10) only octreotide and Group D (n=10) only saline. Effects of the drugs were evaluated in terms of histopathological score, fractional shortening (FS) and prolongation of the QTc interval. Results: Mean pathological score for cardiotoxicity (Group A: 3.7±0.5, Group B: 3.9±0.3), prolongation of QTc (Group A: from 244.5±21.2ms to 282.9±25.9ms, p<0.0001; Group B: from 248.5±17.7ms to 298.3±13.7ms, p<0.00001) and the rate of decrease in FS (Group A: from 34.4 ± 2.0 to 28.0 ± 2.0, p<0.05; Group B: from 35.1 ± 1.9 to 24.8 ± 1.3, p<0.05) were higher in Group B when compared to Group A, but only difference in the rate of decrease in FS was statistically significant (p<0.001). None of these variables changed significantly in groups C and D. Conclusion: In this preliminary study, octreotide seems not to reduce doxorubicin cardiotoxicity. On the other hand, a consistent tendency of decreased cardiotoxicity in octreotide+doxorubicin group was observed, although only the difference in FS decrease was significant. Further investigations are needed to address the issue of the extent and the mechanisms of this effect.

Keywords: Doxorubicin, cardiotoxicity, prevention, octreotide


Cem Barçın, Hürkan Kurşaklıoğlu, Mükerrem Safalı, Atilla İyisoy, Sedat Köse, Nadir Barındık, Ersoy Işık. Effect of octreotide in the prevention of doxorubicin cardiotoxicity. Anatol J Cardiol. 2005; 5(1): 18-23


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share


Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2018 Turkish Society of Cardiology